Skip to Content

New Drug Approvals Archive - March 2004

See also: New Indications and Dosage Forms for March 2004

March 2004

Iquix (levofloxacin ophthalmic) Ophthalmic Solution

Date of Approval: March 1, 2004
Company: Santen
Treatment for: Corneal Ulcers

Marketing Status: Discontinued

Iquix (levofloxacin) is a topical fluoroquinolone indicated for the treatment of bacterial corneal ulcers.

Sensipar (cinacalcet) Tablets

Date of Approval: March 8, 2004
Company: Amgen Inc.
Treatment for: Secondary Hyperparathyroidism, Hypercalcemia of Malignancy

Sensipar (cinacalcet) is a calcimimetic agent indicated for the treatment of secondary hyperparathyroidism in dialysis patients and for the treatment of hypercalcemia in patients with parathyroid carcinoma.

Follistim AQ (follitropin beta) Injection

Date of Approval: March 24, 2004
Company: Organon USA Inc.
Treatment for: Female Infertility, Hypogonadism -- Male, Ovulation Induction

Follistim AQ (follitropin beta) is human follicle-stimulating hormone prescribed for women undergoing assisted reproductive treatments (ART) such as in vitro fertilization (IVF), and for the induction of ovulation to achieve pregnancy, and for men with hypogonadism.

New Drug Approvals Archive

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.